Burlingame, CA, April 21, 2025 (GLOBE NEWSWIRE) — Coherent Market Insights published a report, titled, the global Meperidine (Demerol) Market size is estimated to grow from US$ 507.9 Million in 2025 and is forecast to reach a value of US$ 563.7 Million by 2032 at a CAGR of 1.5% between 2025 and 2032.
Request a Sample of the US Tariff Impact Analysis Report: https://www.coherentmarketinsights.com/insight/request-sample/3816
Global Meperidine (Demerol) Market Key Takeaways
The global meperidine (demerol) market size is anticipated to expand from USD 507.9 Mn in 2025 to USD 563.7 Mn by 2032. Global sales of meperidine (Demerol) will likely increase at a CAGR of 1.5% throughout the forecast period.
By form, tablets segment is projected to account for around USD 284.42 million in 2025. This can be attributed to patients’ preference for meperidine (Demerol) tablets, owing to their convenience, longer shelf life, and ease of storage.
Based on application, anesthesia segment is set to dominate the industry, accounting for a prominent meperidine (Demerol) market share in 2025.
In terms of distribution channel, retail pharmacies segment will likely generate higher market revenues during the forecast period.
North America is expected to remain the undisputed leader in the global meperidine (Demerol) market during the forecast period, owing to high number of surgeries performed and increasing consumption of opioids for pain management. As per Coherent Market Insights’ latest meperidine (Demerol) market analysis, North America is poised to account for around 1/2 of the global market share in 2025.
Asia Pacific remains the second-largest market for meperidine (Demerol), and the trend will likely persist through 2032. This is attributed to increasing prevalence of acute and chronic pain conditions and expanding access to pain management medications, especially across nations like India, China, and Japan.
Get Up to 25% Discount on the US Tariff Impact Analysis Report: https://www.coherentmarketinsights.com/insight/buy-now/3816
Increasing Chronic Pain Prevalence Spurring Sales Growth
A new report by Coherent Market Insights outlines significant meperidine (Demerol) market growth factors. One major factor expected to fuel growth of meperidine (Demerol) industry is the increasing prevalence of chronic pain globally.
According to the International Association for the Study of Pain, around 20% of the adult population globally suffers from chronic pain, making it a significant global health issue. To counter this, people use opioid …